Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02427815
Other study ID # NYULagone
Secondary ID
Status Recruiting
Phase N/A
First received April 20, 2015
Last updated March 27, 2017
Start date May 2014
Est. completion date May 2019

Study information

Verified date March 2017
Source New York University Langone Medical Center
Contact Azizi Seixas, PhD
Phone 646-501-2672
Email azizi.seixas@nyumc.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Reducing sleep health disparities was recognized as a priority area for intervention by the National Institutes of Health. Sleep apnea, which disproportionately affects minorities, is an important preventable and treatable disease that should be targeted as it is associated with increased cardiovascular risk and disease outcomes, including obesity, diabetes, hypertension, stroke, cardiac arrhythmia, and chronic heart failure. Evidence from previous research suggests that most minorities are unaware of general sleep problems, such as sleep apnea symptoms and the negative effects on cardiovascular disease. Only 26% of minorities participating in the investigators prior research followed up on recommended sleep apnea screening, although 39% were at high risk for sleep apnea. While few followed the physician's recommendations, 90% of those assessed received a sleep apnea diagnosis. The investigators research will assess the effectiveness of peer-based sleep health education and social support in increasing sleep apnea screening and treatment rates among minorities with sleep apnea risk. Participants will receive quality-controlled and culturally tailored peer education using a sleep health education manual. They will each receive up to 4 sessions promoting sleep apnea screening during a 6-month period. Those with a diagnosis will receive 2 additional sessions promoting sleep apnea treatment adherence, in conjunction with telephone interventions. The investigators research will also assess the rate of sleep apnea among minorities using home recordings. The long-term goal of the investigators study is to apply this intervention in community-based settings (barbershops, beauty salons, churches, and health centers), thereby linking community health promotion to the healthcare system.


Description:

Primary Aim: To ascertain effectiveness of tailored, peer-based sleep health education and social support in increasing adherence rates to recommended OSA evaluation and treatment among blacks at risk for OSA.

Secondary Aim: To ascertain the rate of OSA among black men and women at the community level using home-based sleep recordings in accordance with criteria from the American Academy of Sleep Medicine.

Hypotheses: Among blacks at risk for OSA, those randomized to receive peer-based sleep health education and social support, compared with those randomized to the attention-control group, will have:

- Greater adherence to physician-recommended OSA evaluation using home sleep recordings.

- Greater adherence to OSA treatment using telemetry (CPAP use [>4 hrs. a night for 70% of the nights]).

- Individual-level factors (OSA knowledge, OSA self-efficacy, and past evaluation behavior) and contextual level factors (i.e., trust/rapport with peer educators, family network, and socioeconomic position) will mediate effects of peer education on adherence to OSA evaluation and recommended treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 398
Est. completion date May 2019
Est. primary completion date May 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- self-reported race/ethnicity as black

- ages =18 years

- accessible by telephone

- no plans to move away from the region within the year following enrollment

- consent to participate, which includes permission to release medical record information

- A positive screening for OSA is necessary to be enrolled in the intervention protocol.

Exclusion Criteria:

- are involved in another sleep study.

- are unable to understand and sign this informed consent form.

- know someone who is participating in this study.

- plan to move away in the next two years.

- had a heart attack or stroke within the past 12 weeks.

- do not identify yourself as Black or African American.

- are pregnant.

- are not at risk for sleep apnea.

- refuse to use the Apnea Risk Evaluation System (ARES) home sleep test device.

Study Design


Intervention

Behavioral:
Intervention Group
Participants randomly assigned to the intervention arm will receive OSA health education and social support from a trained Peer Educator.

Locations

Country Name City State
United States NYULMC Department of Population Health - Center for Healthful Behavior Change New York New York

Sponsors (2)

Lead Sponsor Collaborator
Dr. Girardin Jean-Louis New York University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of participants to adhere to CPAP treatment Following recommended treatment of CPAP machine. 0-12 months
Primary Number of participants to complete home study In this phase the successful completion of a 7 day sleep home study. 0-12 months
Secondary Number of participants to complete a sleep clinic test Participants complete an overnight clinical sleep test for diagnosing obstructive sleep apnea as well as customizing of continuous positive airway treatment. 0-12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A